BofA downgrades Salesforce stock rating on AI transition concerns By Investing.com

BofA Securities initiated Salesforce at Underperform with a $160 price target, implying further downside from a stock already near its 52-week low of $163.52 and down 25% over the past six months. The firm cited muted net new customer additions, limited upsell potential, and a weak AI monetization path, and now models structurally lower growth of about 10% annually. Salesforce also updated its FY2027 revenue reporting structure and expanded its Google Cloud AI partnership, but the analyst downgrade is the main market driver.

Analysis

The key read-through is not just a re-rating of one software name, but a broader compression of terminal-growth assumptions across enterprise software. When a category leader is treated as a mature cash compounder, the market typically starts to discriminate much harder between vendors with real workflow lock-in and those relying on seat expansion or price increases; that is negative for the whole “platform premium” cohort over the next 6-18 months. The newest architecture/revenue reclassification also signals management is trying to make the business easier to underwrite as an annuity, which can be supportive for cash-flow visibility but usually comes at the cost of multiple expansion.

The second-order winner is likely not the obvious AI incumbent, but adjacent infrastructure and integration layers that sit closer to actual workflow execution. If enterprise buyers become more skeptical of “AI monetization” at the app layer, spending should tilt toward tools that improve data plumbing, orchestration, and secure deployment rather than standalone copilot features; that creates a relative advantage for firms with consumption-based expansion and clearer ROI. Conversely, the risk for CRM is that any slowing in net new logo momentum is magnified by weaker upsell, meaning near-term growth can decelerate faster than consensus models expect even if retention remains stable.

For the sector, the bigger catalyst is not quarterly beats but proof of durable AI attach rates over the next 2-3 quarters. If vendors cannot show incremental monetization per user or per workflow, multiples likely continue to compress toward mid-cycle software valuations, especially for names already priced as cash generators. The contrarian view is that the downgrade may be late-cycle and partially priced in, so the stock could stabilize if margin expansion and buybacks offset slower top-line growth; however, that argument is only credible if management avoids any guide-downs tied to AI adoption friction or sales-cycle elongation.

Key Decisions for Investors

• Short CRM on rallies for a 1-3 month horizon; use a defined-risk structure such as buying puts or a put spread into strength. Thesis: multiple compression continues if AI monetization remains qualitative rather than measured, with downside to the prior support zone more likely than a rapid re-rating.
• Pair trade: long NOW / short CRM over the next 1-2 quarters, only if NOW can demonstrate stronger monetization of workflow automation. This expresses a preference for a vendor where automation is embedded in operating spend, not just a standalone narrative.
• Add a relative long in infrastructure-enabled software or data workflow beneficiaries versus app-layer incumbents; best expressed as long a basket of integration/orchestration names against short CRM if capital is limited. The setup favors picks-and-shovels over branded seats.
• Avoid chasing IBM on post-earnings weakness unless guidance improves; treat it as a separate ‘cash return’ trade, not a growth compounder. The cleaner expression of the sector view is to short premium valuation risk rather than buy deep-value software names.
• For longer-horizon investors, wait 1-2 reporting cycles before adding to CRM. Entry is more attractive only after evidence of AI-driven upsell appears in metrics, not commentary; otherwise the downside in estimate revisions likely outweighs any near-term valuation support.